These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 26524327

  • 1. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
    Langan KM, Kotsimbos T, Peleg AY.
    Curr Opin Infect Dis; 2015 Dec; 28(6):547-56. PubMed ID: 26524327
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC, Smyth AR.
    Cochrane Database Syst Rev; 2014 Nov 10; (11):CD004197. PubMed ID: 25383937
    [Abstract] [Full Text] [Related]

  • 3. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P, Whitaker P, Peckham D.
    Curr Med Res Opin; 2012 Jun 10; 28(6):1059-67. PubMed ID: 22401602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Hansen C, Skov M.
    Ther Adv Respir Dis; 2015 Feb 10; 9(1):16-21. PubMed ID: 25471692
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov 10; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 8. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.
    Antoniu S.
    Expert Rev Anti Infect Ther; 2015 Jul 10; 13(7):897-905. PubMed ID: 25921312
    [Abstract] [Full Text] [Related]

  • 9. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D, Stableforth D.
    Drugs; 2000 Nov 10; 60(5):1053-64. PubMed ID: 11129122
    [Abstract] [Full Text] [Related]

  • 10. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M, Nazareth D, Walshaw M.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug 10; 27(4):299-305. PubMed ID: 24219814
    [Abstract] [Full Text] [Related]

  • 11. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J, Schwarz C, Sommerwerck U, Nash EF, Tamm M, Cao W, Mastoridis P, Debonnett L, Hamed K.
    Ther Adv Respir Dis; 2017 Jul 10; 11(7):249-260. PubMed ID: 28614995
    [Abstract] [Full Text] [Related]

  • 12. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Taccetti G, Bianchini E, Cariani L, Buzzetti R, Costantini D, Trevisan F, Zavataro L, Campana S, Italian Group for P aeruginosa Eradication in Cystic Fibrosis.
    Thorax; 2012 Oct 10; 67(10):853-9. PubMed ID: 22379071
    [Abstract] [Full Text] [Related]

  • 13. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
    Griese M, Müller I, Reinhardt D.
    Eur J Med Res; 2002 Feb 21; 7(2):79-80. PubMed ID: 11891148
    [Abstract] [Full Text] [Related]

  • 14. Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.
    Antonela Antoniu S.
    Expert Rev Anti Infect Ther; 2012 Dec 21; 10(12):1439-46. PubMed ID: 23253321
    [Abstract] [Full Text] [Related]

  • 15. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL, Smyth AR, Brown M, Jones AP, Hickey H, Kenna D, Ashby D, Thompson A, Williamson PR, TORPEDO-CF study group.
    Lancet Respir Med; 2020 Oct 21; 8(10):975-986. PubMed ID: 33007285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D, Henig N, Morrissey B, Gotfried M.
    Chest; 2006 Nov 21; 130(5):1503-10. PubMed ID: 17099030
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.